← Eichor
Study identifier: NCT07596706 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Crossover vs Accurate Ostial PCI for Medina 0.0.1 and 0.1.0 Left Main Bifurcation Lesions

Condition: Coronary Bifurcation Lesion · Coronary Artery Disease (CAD) · Left Main Coronary Artery Stenosis  ·  Sponsor: Istanbul Mehmet Akif Ersoy Educational and Training Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Coronary artery disease is a leading cause of mortality and morbidity globally. The left coronary artery system is critically important due to its supply of a large area of myocardium. Ostia lesions of left anterior descending artery \[LAD\] and circumflex artery \[CX\]) present technical challenges during percutaneous coronary intervention (PCI) and are considered high-risk lesions due to their anatomical location, relationship with the left main coronary artery bifurcation. Two main approaches exist for treating these lesions: accurate ostial stenting and crossover stenting extending from the left main coronary artery to the relevant branch. Accurate ostial stenting aims to avoid unnecessary stenting of the left main coronary artery, while crossover stenting is more advantageous in terms of ensuring complete coverage of the ostial region. However, the crossover approach may have disadvantages such as larger stent implantation and potential side branch involvement. The current literature does not clearly define the clinical superiority of these two strategies. While various studies have shown no significant difference in mortality, myocardial infarction, and target lesion revascularization, the results are heterogeneous, and a definitive consensus has not been reached. The majority of current data are based on retrospective or observational studies. Therefore, well-designed prospective studies comparing crossover stenting and accurate ostial stenting strategies in the ostial…

This description comes directly from the study's public registry record.

Talk to the study team

Ahmet Güner, MD  ·  +90212692200  ·  ahmetguner488@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery HospitalIstanbul, Please Select, Turkey (Türkiye)Active Not Recruiting
İstanbul Mehmet Akif Ersoy Thoracic And Cardiovascular Surgery Training and Research HospitalIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07596706